Individualized Homeopathic Medicines in the Treatment of Knee Osteoarthritis: Double-Blind, Randomized, Placebo-Controlled Feasibility Trial
Authors:
- Soumya BhattacharyyaSBSoumya Bhattacharyya
- Chandrima ChatterjeeCCChandrima Chatterjee
- Subhranil SahaSSSubhranil Saha
- Satyajit NaskarSNSatyajit Naskar
- Pulakendu BhattacharyaPBPulakendu Bhattacharya
- Sk Monsur AlamSASk Monsur Alam
- Sumana SenguptaSSSumana Sengupta
- Sabir AhamedSASabir Ahamed
- Abdur R. ShaikhASAbdur R. Shaikh
- Munmun KoleyMKMunmun Koley
- Priyanka GhoshPGPriyanka Ghosh
- Shyamal K. MukherjeeSMShyamal K. Mukherjee
- 25 September 2023
- journal article
- research article
- Published by Georg Thieme Verlag KG in Homeopathy
- Vol. 113 (03) , 158-166
Abstract
Introduction This study aimed at examining the feasibility issues of comparing individualized homeopathic medicines (IHMs) with identical-looking placebos for treating knee osteoarthritis (OA). Methods Forty eligible patients participated in this double-blind, randomized (1:1), placebo-controlled feasibility trial in the outpatient clinics of a homeopathic hospital in West Bengal, India. Either IHMs or identical-looking placebos were administered, along with mutually agreed-upon concomitant care guidelines. The Knee Injury and Osteoarthritis Outcome Score (KOOS) was the primary outcome measure, along with derived Western Ontario and McMaster Universities Arthritis Index (WOMAC) scores from KOOS. The EQ-5D-5L questionnaire and Visual Analog Scale (VAS) were the secondary outcomes. All were measured at baseline and after 2 months. Group differences and effect sizes (Cohen's d) were estimated using an intention-to-treat approach. p-Values less than 0.05 (two-tailed) were considered statistically significant. Results Enrolment/screening and trial retention rates were 43% and 85% respectively. Recruitment was difficult owing to the coronavirus disease 2019 (COVID-19) lockdown. Group differences were statistically significant, favoring IHMs against placebos in all the KOOS sub-scales: symptoms (p < 0.001), pain (p = 0.002), activities of daily living (p < 0.001), sports or recreation (p = 0.016), and quality of life (p = 0.002). Derived WOMAC scores from KOOS favored IHMs against placebos: stiffness (p < 0.001) and pain (p < 0.001). The EQ-5D-5L questionnaire score (p < 0.001) and EQ-5D-5L VAS scores (p < 0.001) also yielded significant results, favoring IHMs over placebos. All the effect sizes ranged from moderate to large. Sulphur was the most frequently prescribed homeopathic medication. Neither group reported any harm or serious adverse events. Conclusion Although recruitment was sub-optimal due to prevailing COVID-19 conditions during the trial, the action of IHMs was found to be superior to that of placebos in the treatment of knee OA. Larger and more definitive studies, with independent replications, are warranted in order to substantiate the findings. Trial registration: CTRI/2021/02/031453.Keywords
This publication has 24 references indexed in Scilit:
- A Double-Blind Randomized Placebo-Controlled Feasibility Study Evaluating Individualized Homeopathy in Managing Pain of Knee OsteoarthritisJournal of Evidence-Based Complementary & Alternative Medicine, 2015
- Documentation of Prescriptions and Clinical Outcomes in a Homeopathic Hospital Setting in West Bengal, IndiaJournal of Evidence-Based Complementary & Alternative Medicine, 2015
- Clinical trials of homoeopathy in osteoarthritis: A systematic reviewOA Alternative Medicine, 2013
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- Reporting data on homeopathic treatments (RedHot): a supplement to CONSORTHomeopathy, 2007
- The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritisHealth and Quality of Life Outcomes, 2003
- Knee injury and Osteoarthritis Outcome Score (KOOS) – validation and comparison to the WOMAC in total knee replacementHealth and Quality of Life Outcomes, 2003
- Homeopathic remedies for the treatment of osteoarthritis: a systematic reviewBritish Homoeopathic journal, 2001
- Knee Injury and Osteoarthritis Outcome Score (KOOS)—Development of a Self-Administered Outcome MeasureJournal of Orthopaedic & Sports Physical Therapy, 1998
- Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the kneeArthritis & Rheumatism, 1986